high blood pressure and semaglutide How for influences weight loss International Clinical Trial Finds that

Zhang J, Zhu G, Wan L, Liang Y, Liu X, Yan H, Zhang B, Yang G (2023) Effect of fecal microbiota transplantation in children with autism spectrum disorder: a systematic review

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis

Conclusions Combination therapy with SGLT2is and GLP-1RAs represents a major advance in the management of type 2 diabetes, targeting residual cardiometabolic risk through complementary mechanisms

Phase 2 clinical trial data (published in NEJM and related journals) have reported dose-dependent effects on body weight, glycaemic markers, and hepatic fat in human metabolic-disease populations but Retatrutide remains investigational and is supplied strictly as a research compound

doi:10.1111/andr.12191